What known clinical indications are not receptive to treatment with the MC-5A
device?
Determining clinical indications that are and are not receptive to
treatment with the Calmare® device is ongoing and specific to the
underlying causes to a particular patient’s pain. It is important to
note that “Not Receptive” refers only to patients who do not have
benefits after a treatment cycle, or where it is not possible to
identify the correct area or dermatomes to treat. This is highly
dependent on the clinician/technician skills and ability to correctly
identify the correct area(s) for placement of the electrodes. A rapid
pain relapse after the treatment cycle occurs in an evolutionary
pathology, or in the presence of mechanic or inflammatory causes
that continuously damage the nervous tissue. In these cases, the
therapy should be carried out continuously every time the pain
appears, since a single cycle is not sufficient to adequately treat an
unstable situation of nervous tissue damage. It has also been
noticed that anticonvulsant drugs reduce the medium – long-term
efficacy retention, while analgesics, such as anti-inflammatory or
paracetamols have proven to be synergistic.